Benchmark of the Oxford Nanopore, EM-seq, and HumanMethylationEPIC BeadChip for the detection of the 5mC sites in cancer and normal samples
Frontiers in Epigenetics and Epigenomics · 2024
DOI: 10.3389/freae.2024.1362926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Epigenetics and Epigenomics, 2024. Verfasst von Kseniia A Deinichenko und 20 weiteren Autor:innen. Beteiligte Einrichtung: Federal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Whole-genome DNA methylation identification is crucial for profiling physiologically and clinically relevant epigenetic changes. Although there are multiple experimental methods, their accuracy, advantages, and disadvantages need to be investigated in their application to complex tissue objects. In this study, we performed a benchmark of 5mC detection with Oxford Nanopore and enzymatic methyl-sequencing (EM-seq) methods. Material and Methods: To this end, we profiled in a genome-wide manner 5mC sites in colorectal tumors and normal tissues for three patients and applied the HumanMethylationEPIC BeadChip as an additional control approach. We estimated the whole-genome scale of the methylation detection that each method yields.
Results
Our investigation describes the sensitivity and specificity of each platform and the impact that sequencing coverage brings. Our analysis revealed the higher sensitivity and specificity of Nanopore sequencing over the EM-seq method. Moreover, Oxford Nanopore Technology (ONT) sequencing, followed by Megalodon methylation detection, demonstrates better quantitative agreement of the epigenetic signals between biological replicates. Furthermore, our analysis highlights that with 40× and above coverage, EM-seq slightly outperforms ONT and yields highly accurate detection of the 5mC signals (AuPR = 0.99178 and AuROC = 0.98161).
Conclusion
The study was performed on colon cancer and adjacent normal tissue samples, placing our investigation close to the real application of methylation studies in oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Federal State Budgetary Institution Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency (Centre for Strategic Planning of FMBA of Russia), Moscow, Russia.
- Federal State Budgetary Institution N.N. Blokhin National Medical Research Cener of Oncology of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia.
- Federal Medical Biological Agency (FMBA of Russia), Moscow, Russia.
Zitieren
APA
Deinichenko, K. A., Vynogradskaya, V. G., Grebnev, P. A., Mikova, V. M., Bobylev, D. O., Shaymardanov, A. M., Ivashechkin, A. A., Erokhina, M. V., Akinshina, A. I., Semyanihina, A. V., Mitrofanov, S. I., Grammatikati, K. S., Yudin, V. S., Yudin, S. M., Makhotenko, A. V., Keskinov, A. A., Kraevoy, S. A., Makarova, A. S., Snigir, E. A., …, & Skvortsova, V. I. (2024). Benchmark of the Oxford Nanopore, EM-seq, and HumanMethylationEPIC BeadChip for the detection of the 5mC sites in cancer and normal samples. Frontiers in Epigenetics and Epigenomics. https://doi.org/10.3389/freae.2024.1362926
Vancouver
Deinichenko KA, Vynogradskaya VG, Grebnev PA, Mikova VM, Bobylev DO, Shaymardanov AM, et al. Benchmark of the Oxford Nanopore, EM-seq, and HumanMethylationEPIC BeadChip for the detection of the 5mC sites in cancer and normal samples. Frontiers in Epigenetics and Epigenomics. 2024. doi:10.3389/freae.2024.1362926
BibTeX
@article{Deinichenko2024,
author = {Deinichenko, Kseniia A and Vynogradskaya, Valentina G and Grebnev, Pavel A and Mikova, Valeriya M and Bobylev, Dmitriy O and Shaymardanov, Abusaid M and Ivashechkin, Alexey A and Erokhina, Marina V and Akinshina, Alexandra I and Semyanihina, Anna V and Mitrofanov, Sergey I and Grammatikati, Konstantin S and Yudin, Vladimir S and Yudin, Sergey M and Makhotenko, Antonida V and Keskinov, Anton A and Kraevoy, Sergey A and Makarova, Anna S and Snigir, Ekaterina A and Svetlichnyy, Dmitry V and Skvortsova, Veronika I},
title = {Benchmark of the Oxford Nanopore, EM-seq, and HumanMethylationEPIC BeadChip for the detection of the 5mC sites in cancer and normal samples},
journal = {Frontiers in Epigenetics and Epigenomics},
year = {2024},
doi = {10.3389/freae.2024.1362926}
}
EUVIMED